Extract
Chronic breathlessness is a dominating symptom that restricts daily life for many people with cardiorespiratory disease [1]. Different dimensions of the symptom, such as the intensity, sensory qualities (SQs) and emotional responses, can be assessed using the instruments Dyspnea-12 (D-12) [2] and the Multidimensional Dyspnea Profile (MDP) [3], which share similarities in the underlying constructs of what is measured [4] and have emerged as widely used instruments for multi-dimensional measurement of breathlessness.
Footnotes
This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.
Conflict of interest: Dr. Ekström has nothing to disclose.
Conflict of interest: Dr. Bornefalk has nothing to disclose.
Conflict of interest: Dr. Sköld has nothing to disclose.
Conflict of interest: Dr. Jansson has nothing to disclose.
Conflict of interest: Dr. Blomberg has nothing to disclose.
Conflict of interest: Dr. Sandberg has nothing to disclose.
Conflict of interest: Dr. Bornefalk-Hermansson has nothing to disclose.
Conflict of interest: Dr. Currow reports he is an unpaid advisory board member for Helsinn Pharmaceuticals. He is a paid consultant and receives payment for intellectual property with Mayne Pharma and is a consultant with Specialised Therapeutics Australia Pty. Ltd.
Conflict of interest: Dr. Johnson has nothing to disclose.
Conflict of interest: Dr. Sundh has nothing to disclose.
- Received July 17, 2020.
- Accepted November 5, 2020.
- Copyright ©ERS 2020
LIBRARY USERS
Log in through your institution
Purchase access
